Left Ventricular Remodelling during Treatment with β-Blockers

Yusuf S Peto R Lewis J Collins R Sleight P . Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; XXVII: 335–371.

Packer M Bristow MR Cohn JN Colucci WS Fowler MB Gilbert EM for the USA Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349–1355.

Swedberg K Held P Kjekshus J Rasmussen K Rydén L Wedel H . Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 327: 678–684.

Herlitz J Holmberg S Pennert K Swedberg K Vedin A Waagstein F Göteborg Metoprolol Trial: patient characteristics and conduct. Am J Cardiol 1984; 53: 3D–8D.

The MIAMI trial research group. Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial. Eur Heart J 1985;6: 199–226.

Ertl G Neubauer S Gaudron P Horn M Hu K Tian R Beta-blockers in cardiac failure. Eur Heart J 1994; 15 (suppl C): 16–24.

Lechat P Escolano S Golmard JL Lardoux H Witchitz S Henneman JA Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the cardiac insufficiency bisoprolol study (CIBIS). Circulation 1997;96: 2197–2205. References [7,34–37] are publications of clinical studies on the effect of β-blockers on patients with left ventricular dysfunction. The results are controversial. Administration of the ‘pure β-blocker’ bisoprolol had no effect on left ventricular volume for 46% of patients who had had heart failure of ischaemic aetiology. In contrast, in three studies in which 100% of patients had had heart failure of ischaemic aetiology and vasodilator β-blockers (bucindolol and carvedilol) were used, left ventricular dilatation was prevented or a tendency towards a smaller left ventricular volume was achieved. Since authors of these articles do not report pressure–volume relationships, it might well be that reduction of loading shifted the volume towards apparently smaller volumes extrapolated from the pressure–volume curve without there being a true structural reduction of volume. Only the latter can be considered an effect on remodelling. Although these reports concern all the clinical data thus far available, they do not prove that administration of β-blockers has an effect on remodelling.

Francis GS Benedict C Johnstone DE Kirlin PC Nicklas J Liang CS Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990; 82: 1724–1729.

Benedict CR Shelton B Johnstone DE Francis G Greenberg B Konstam M Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996; 94: 690–697.

Fraccarollo D Hu K Galuppo P Gaudron P Ertl G . Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction. Possible involvement of myocardial endothelin system in ventricular remodeling. Circulation 1997; 96: 3963–3973.

Hodsman GP Kohzuki M Howes LG Sumithran E Tsunoda K Johnston CI . Neurohumoral responses to chronic myocardial infarction in rats. Circulation 1988; 78: 376–381.

Howes LG Hodsman GP Maccarone C Kohzuki M Johnston CI . Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels in a rat model of left ventricular failure. J Cardiovasc Pharmacol 1989; 13: 348–352.

Ertl G . Coronary vasoconstriction in experimental myocardial ischemia. J Cardiovasc Pharmacol 1987 9 (suppl 2): S9–S17.

Heilbrunn SM Shah P Bristow MR Valantine HA Ginsburg R Fowler MB . Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989; 79: 483–490.

Steinberg SF Zhang HL Pak E Pagnotta G Boyden PA . Characteristics of the β-adrenergic receptor complex in the epicardial border zone of the 5-day infarcted canine heart. Circulation 1995; 91: 2824–2833.

Fellenius E Hansen CA Miøs O Neely AJR . Chronic infarction decreases maximum cardiac work and sensitivity of heart to extracellular calcium. Am J Physiol 1985; 249: H80–H87.

Itaya T Hashimoto H Uematsu T Nakashima M . Alterations of responsiveness to adrenoceptor agonists and calcium of non-infarcted hypertrophied muscles from rats with chronic myocardial infarction. Br J Pharmacol 1990; 99: 572–576.

Gengo PJ Sabbah HN Steffen RP Sharpe JK Kono T Stein PD Myocardial beta-adrenoceptor and voltage sensitive calcium channel changes in a canine model of chronic heart failure. J Mol Cell Cardiol 1992;24: 1361–1369.

Hochman JS Wong SC . Effect of atenolol on myocardial infarct expansion in a nonreperfused rat model. Am Heart J 1991; 122: 689–694. See annotation [21].

Fishbein M Lei LQ Rubin SA . Long-term propranolol administration alters myocyte and ventricular geometry in rat hearts with and without infarction. See annotation [21].

Oh BH Ono S Gilpsin E Ross J . Altered left ventricular remodeling with β-adrenergic blockade and exercise after coronary reperfusion in rats. Circulation 1993; 87: 608–616. Authors of [19–21] report adverse effects of β-blockers on the rat model of myocardial infarction and chronic left ventricular dysfunction.

Sabbah HN Shimoyama H Kono T Gupta RC Sharov VG Scicli G Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 1994; 89: 2852–2859.

Warner AL Bellah KL Raya TE Roeske WR Goldman S . Effects of β adrenergic blockade on papillary muscle function and the β-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction. Circulation 1992; 86:1584–1595. Authors of this article suggest that contractility of non-infarcted myocardium is preserved in this model of chronic left ventricular dysfunction after myocardial infarction.

Hu K Gaudron P Ertl G . Chronic effects of betablocker treatment on hemodynamics and left ventricular remodeling in rats with experimental myocardial infarction. Importance of timing of treatment and infarct size. J Am Coll Cardiol 1998; 31: 692–700. This article clarifies the controversy around experimental studies of animals and clinical results by providing proof that effects of administration of β-blockers after myocardial infarction depend on size of infarct and timing of treatment.

Neubauer S Krahe T Schindler R Horn M Hillenbrand H Entzeroth CH ³¹P-magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease – altered cardiac high energy phosphate metabolism in heart failure. Circulation 1992; 86: 1810–1818.

Neubauer S Horn M Cramer M Harre K Newell JB Peters W Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997; 96: 2190–2196.

Katz AM . The myocardium in congestive heart failure. Am J Cardiol 1989; 63: 12A–16A.

Neubauer S Horn M Naumann A Tian R Hu K Laser M Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest 1995; 95: 1092–1100.

Michel JB Lattion AL Salzmann JL De Lourdes Cerol M Philippe M Camilleri JP Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988; 62: 641–650.

Laser A Neubauer S Tian R Hu K Gaudron P Ingwall JS Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction. J Am Coll Cardiol 1996; 27: 487–493. Authors of this article suggest a mechanism of preservation of function of surviving myocardium by β-blockers after myocardial infarction. The shift of cardiac proteins (including myosin) and, in this particular study, of high-energy-metabolization enzymes towards an embryonic pattern is prevented by administration of β-blockers and contractility can thereby be preserved.

Sharpe N Murphy J Smith H Hannan S . Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1988; I: 255–259.

Pfeffer JM Pfeffer MA Braunwald E . Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985; 57: 84–95.

St John Sutton M Pfeffer MA Plappert T Rouleau JL Moyé LA Dagenais GR Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994; 89: 68–75.

Eichhorn EJ Bedotto JB Malloy CR Hatfield BA Deitchman D Brown M Effect of β-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. Circulation 1990; 82: 473–483.

See annotation [7].

Woodley SL Gilbert EM Anderson JL O'Connell JB Deitchman D Yanowitz FG β-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991; 84: 2426–2441.

See annotation [7].

Australia–New Zealand Heart Failure Research Collaborative Group. Effects of carvedilol, a vasodilator–β-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 1995; 92: 212–218.

See annotation [7].

Doughty RN Whalley GA Gamble G MacMahon S Sharpe N , on behalf of the Australian–New Zealand Heart Failure Research Collaborative Group. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 1997;29: 1060–1066.

See annotation [7].